The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer-Reference-Cited by-同舟云学术

The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer

Published:1986-07 Issue:1 Volume:155 Page:56-60
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Niloff Jonathan M.,Knapp Robert C.,Lavin Philip T.,Malkasian George D.,Berek Jonathan S.,Mortel Rodrigue,Whitney Charles,Zurawski Vincent R.,Bast Robert C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference15 articles.

1. Second-look operations in ovarian cancer;Schwartz;Am J Obstet Gynecol,1980

2. Common epithelial cancer of the ovary;Richardson;N Engl J Med,1985

3. Ovarian carcinoma—a decade of progress;Piver;Cancer,1984

4. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status;Berek;Obstet Gynecol,1984

5. Microscopic disease at second-look procedures for ovarian cancer;Copeland;Am J Obstet Gynecol,1985

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of [18F]FDG PET/CT examination in the detection and differentiation of recurrent ovarian cancer;Nuclear Medicine Review;2023-02-16

2. Predictive Value of HE4 in Platinum-Based Chemotherapy for Ovarian Cancer: A Systematic Review;Frontiers in Oncology;2021-07-08

3. PET/CT for Evaluation of Ovarian Cancer;Seminars in Nuclear Medicine;2019-11

4. The Role of ¹⁸F-FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 Levels;Molecular Imaging and Radionuclide Therapy;2019-02-01

5. Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma;Journal of Gynecologic Oncology;2019